LHC BIBLIOGRAPHY

2006-PRESENT

Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R. L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C. C. and Croce, C. M.: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA, 103: 2257-2261, 2006.

Spillare, E. A., Wang, X. W., von Kobbe, C., Bohr, V. A., Hickson, I. D. and Harris, C.C.: Redundancy of DMA helicases in p53-mediated apoptosis. Oncogene. 25: 2119-2123, 2006.

Goodman, J. E., Mechanic, L. E., Luke, B. T., Ambs, S., Chanock, S. and Harris, C. C.: Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int.J.Cancer, 118: 1790-1797, 2006.

Yanaihara, N., Caplen, N., Bowman, E., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., Calin, G. A., Liu, C.-G., Croce, C. M. and Harris, C. C.: microRNA expression signature predicts lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.

Okano, T., Gemma, A., Hosoya, Y., Hosomi, Y., Nara, M., Kokubo, Y., Yoshimura, A., Shibuya, M., Nagashima, M., Harris, C. C. and Kudoh, S.: Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Oncol. Rep. 15: 545-549, 2006.

Bonner, M. R., Bennett, W. P., Xiong, W., Lan, Q., Brownson, R. C., Harris, C. C., Field, R. W., Lubin, J. H. and Alavanja, M. C.: Radon, secondhand smoke, glutathione-S-transferase M1 and lung cancer among women. Int. J. Cancer, 119: 1462-1467, 2006.

Pine, S. R., Mechanic, L. E., Bowman, E. D., Welsh, J. A., Chanock, S. C., Shields, P. G. and Harris, C. C.: MDM2 SNP309 and SNP354 are not associated with lung cancer risk. Cancer Epidemiol. Biomarkers and Prev., 15: 1559-1561, 2006.

Hagiwara, N., Mechanic, L. E., Trivers, G. E., Cawley, H. L., Taga, M., Bowman, E. D., Kumamoto, K., He, P., Bernard, M., Doja, S., Miyashita, M., Tajiri, T., Sasajima, K., Nomura, T., Makino, H., Takahashi, K., Hussain, S. P. and Harris, C. C.: Quantitative detection of p53 mutations in plasma DNA from tobacco smokers. Cancer Res. 66: 8309-8317, 2006.

Thomas, D. D., Ridnour, L. A., Espey, M. G., Donzelli, S., Ambs, S., Hussain, S. P., Harris, C. C., DeGraff, W., Roberts, D. D., Mitchell, J. B. and Wink, D. A.: Superoxide fluxes limit nitric oxide-induced signalling. J. Biol. Chem. 281: 25984-25993, 2006.

Unoki, M., Shen, J. C., Zheng, Z. M. and Harris, C. C.: Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility. J. Biol. Chem., 281: 34677-34686, 2006.

Wu, C. G., Budhu, A., Chen, S., Zhou X., Ionescu, N. C., Valerie, K. and Wang, X. W.: Effect of Hepatitis C virus Core Protein on the Molecular Profiling of Human B lymphocyte. Mol Med 12: 47-53, 2006.

Lambaa, J. K., Chen, X., Lan, L. B., Kim, J. W., Wang, X. W., Relling, M. V. Kazuto, Y., Watkins, P. B, Strom, S., Sun, D., Schuetz, J. D. and Schuetz, E. G.: Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humans. Pharmacogenetics and Genomics 16: 415-427, 2006.

Budhu, A., Forgues, M., Ye, Q. H., Jia, H. L., He, P., Zanetti, K. A., Kammula, U. S., Chen, Y., Qin, L. X., Tang, Z. Y. and Wang, X. W.: Prediction of metastatic potential and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10: 99-111, 2006.

Budhu, A and Wang, X.W.: Role of cytokines in hepatocellular carcinoma. J. Leukocyte Biology 80: 1197-1213. 2006.

Lim, M. J. and Wang, X. W.: Nucleophosmin and human cancer. Cancer Detection and Prevention 30: 481-490, 2006.

Budhu, A. and Wang, X. W.: The role of nucleophosmin in Ran/Crm1-mediated centrosome duplication. Center for Cancer Research Frontiers in Science, 5, 2006.

Nunez N, Rosenberg J, Oh WJ, Perella C, Anver M, Pekins SN, Varticovski L, Hursting SD, and Vinson C. Accelerated Tumor Formation in a Fatless Mouse with Type 2 Diabetes and Inflammation. Cancer Res. 2006, 66: 5469-5476.

Antony S, Agama KK, Miao Z-H, Hollingshead MG, Holbek SL, Wright MH, Varticovski L, Nagarayan M, Morell A, Cushman M, and Pommier Y. Bisindenoisoquinoline NSC 727357, a DNA intercalator and topoisomerase inhibitor with antitumor activity. Mol Pharm, 2006, 10:1124-1129.

Robles AI, Wright MH, Gandhi B, Feis S, Hanigan CL, and Varticovski L. Schedule-dependent Synergy between the HSP90 inhibitor 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin (DMAG) and Doxorubicin restores apoptosis to p53-mutant lymphoma cells. Clin Cancer Res. 2006, 12; 6547-56.

Mechanic, L. E., Bowman, E. D., Welsh, J. A., Khan, M. A., Hagiwara, N., Enewold, L., Shields, P. G., Burdette, L., Chanock, S. and Harris, C. C.: Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors. Cancer Epidemiol. Biomarkers Prev. 16: 214-222, 2007.

Koshiji, M., Kumamoto, K., Morimura, K., Utsumi, Y., Aizawa, M., Hoshino, M., Sekikawa, K., Takenoshita, S., Costa, M., Commes, T., Piquemal, D., Harris, C. C., and Tchou-Wong, K.-M.: Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity. World J Gastroenterology 13: 2803-2810, 2007.

Shen, J. C., Unoki, M., Ythier, D., Dupperray A., Varticovski, L., Kumamoto, K., Pedeux, R. and Harris, C. C.: Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin 1. Cancer Res., 67: 2552-2558, 2007.

Budhu, A., Chen, Y., Kim, J., Forgues, M., Valerie, K., Harris, C. C. and Wang, X. W.: Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS5A proteins. Carcinogenesis, 28: 1552-1560, 2007.

Seike, M., Yanaihara, N., Bowman, E. D., Zanetti, K. A., Budhu, A., Kumamoto, K., Mechanic, L. E., Matsumoto, S., Yokota, J., Shibata, T., Sugimura, H., Gemma, A., Kudoh, S., Wang, X. W., and Harris, C. C.: Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. J. N. C. I., 99: 1257-1269, 2007.

Pine, S. R., Mechanic, L. E., Ambs, S., Bowman, E. D., Chanock, S. J., Loffredo, C.., Shields, P. G., and Harris, C. C.: Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J. N. C. I., 99: 1401-1409, 2007.

Yoshikawa, H., Matsubara, K., Zhou, X., Okamura, S., Kubo, T., Murase, Y., Shikauchi, Y., Esteller, M., Herman, J. G., Wang, X. W. and Harris, C. C.: WNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer. Molec. Biol. Cell, 18: 4292-4303, 2007.

Bernig, T., Boersma, B.J., Howe, T.M., Welch, R., Yadavalli, S., Staats, B., Mechanic, L.E., Chanock, S.J., and Ambs, S. The Mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African American and Caucasian women. Carcinogenesis, 28: 828-836, 2007.

Crawford, N.P.S., Qian, X., Ziogas, A., Papageorge, A.G., Boersma, B.J., Walker, R.C., Lukes, L., Rowe, W.H., Zhang, J., Ambs, S., Lowy, D.R., Anton-Culver, H., and Hunter, K.W. Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLOS Genetics, 3: e214, 2007.

Prueitt, R.L., Yi, M., Hudson, R.S., Wallace, T.A., Howe, T.M., Yfantis, H.G., Stephens, R.M., Liu, C.-G., Calin, G.A., Croce, C.M., and Ambs, S. MicroRNA and mRNA expression profiles associated with perineural invasion in prostate cancer. The Prostate, submitted.

Jia, H. L., Ye, Q. H., Qin, L. X., Budhu, A., Forgues, M., Chen, Y., Liu, Y. K., Sun, H. C., Wang, L., Lu, H. Z., Shen, F., Tang, Z. Y. and Wang, X. W.: Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin. Cancer Res. 13: 1133-1139, 2007.

Takafuji, V., Forgues, M., Unsworth, E., Goldsmith, P. and Wang, X. W.: An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene: April 23, 2007, [Epub ahead of print].

Chen, X. C., Yu, B., Dong, J. C., Gu, Y. X., Chen, L., Wu, Q. Z., Hou, N. P., Liu, J. X., Xu, J. T., Jin, R. X., Jin, G. Q., Yang, X. D., Cao, Y. W., Tan, J. J., Zhu, B., Shen, J. C., Xu, Z., Varticovski, L. and Wang, X. W.: A Phase II Clinical Trial with Cytotropic Heterogeneous Molecular Lipids (CHML®) for Patients with Hepatic Malignancies. Anticancer Res, 27: 1593-1600, 2007.

Budhu, A., Chen, Y., Kim, J. W., Forgues, M., Valerie, K., Harris, C. C. and Wang, X. W.: Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. Carcinogenesis 28: 1552-1560, 2007.

Roessler, S., Budhu, A., Wang, X. W.: Future of molecular profiling of human hepatocellular carcinoma. Future Oncol., 3: 429-439, 2007.

Varticovski L, Hollingshead MG, Robles AI, Carter JP, Borgel SP, Stotler H, Bonomi CA, Anver MR, Nunez N, Hursting S, Qiao W, Deng CX, Green JE, Hunter KW, Merlino G, Steeg PS, Wakefield L, and Barrett JC. Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models. Clin Cancer Res. 2007, 13: 2168-77

Varticovski L, and Robles AI. Harnesing genetically engineered mouse models for drug development. Frontiers in Toxicology, Chemico-Biological Interactions. 2007, 171:159–164.

Hursting SD., Nunez NP, Varticovski L, and Vinson C. The obesity-cancer link: lessons learned from a fatless mouse. Cancer Res. 2007, 67: 2391-3.

Antony S, Agama KK, Miao ZE-H, Hollingshead MG, Holbek SL, Wright MH, Varticovski L, Nagarajan M, Morell A, Cushman M, and Pommier, Y. Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance. Cancer Res. 2007, 67:10397-411

Nunez N, Perkins S, Smith N, Berrigan D, Varticovski L, and Hursting SD. Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutr Cancer, 2007 (in press).

Pine S, Marshall B, and Varticovski L. Lung Cancer Stem Cells. Special Edition of Cancer Biomarkers. Stem Cells and Cancer. 2007, in press

Boersma, B.J., Reimers, M., Yi, M., Ludwig, J.A., Luke, B.T., Stephens, R.M., Yfantis, H.G., Lee, D.H., Weinstein, J.N., and Ambs, S. A stromal gene signature associated with inflammatory breast cancer. Int. J. Cancer, 122: 1324-1332, 2008.

Wallace, T.A., Prueitt, R.L., Yi, M., Howe, T.M., Gillespie, J.W., Yfantis, H.G., Stephens, R.M., Caporaso, N.E., Loffredo, C.A., and Ambs, S. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res., 68: 927-936, 2008.

Ambs, S., Prueitt, R.L., Yi, M., Hudson, R.S., Howe, T.M., Petrocca, F., Wallace, T.A., Liu, C.-G., Volinia S., Calin, G.A., Yfantis, H.G., Stephens, R.M., and Croce, C.M. Genomic profiling of microRNA and mRNA reveals deregulated microRNA expression in prostate cancer. Cancer Research., submitted.

Aaron J. Schetter, PhD, MPH; Suet Yi Leung, MD; Jane J. Sohn, PhD; Krista A. Zanetti, PhD, MPH; Elise D. Bowman, MS; Nozomu Yanaihara, MD, PhD; Siu Tsan Yuen, MD; Tsun Leung Chan, MD; Dora L. W. Kwong, MD; Gordon K. H. Au, MD; Chang-Gong Liu, PhD; George A. Calin, MD, PhD; Carlo M. Croce, MD; Curtis C. Harris, MD . MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma. JAMA., (299):4, 2008

Wright MH, Robles AI, Herschkowitz JI, Hollingshead MG, Anver MR, Perou CM, and Varticovski L. Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1. Mol Cancer, 2008, in press.